Skip to content

Thinking About Prescribing

The Psychology of Psychopharmacology With Diverse Youth and Families

Edited by Shashank V. Joshi, M.D., FAAP, DFAACAP, and Andrés Martin, M.D., M.P.H.

Pre-Order
  • ISBN 978-1-61537-388-8
  • Item #37388
Coming January 2022!

View Pricing

List Price
$65.00

APA Members
$52.00

20% off

APA Resident-Fellow Members
$48.75

25% off

Buying In Canada or Europe?

Description

Our remedies are only as good as the way in which we dispense them

That's the central premise of Thinking About Prescribing, a new volume that encourages pharmacotherapists to view the prescribing of a psychiatric medication to young patients not simply as part of a clinical visit, but rather as the beginning of an ongoing alliance with youth and their parents or legal guardians.

The book makes the case for a partnership that doesn't lean on psychiatric jargon or an encyclopedic list of side effects, but instead on measured candor, vulnerability, and—most importantly—time.

Thinking About Prescribing leverages the knowledge of more than two dozen experts as it tackles topics that include:

  • The essential features of the Common Factors approach and the Y-model of psychotherapy, which highlights how relational aspects of pharmacotherapy are key to child & adolescent psychiatric practice, even for brief visits
  • How best to utilize the 30-minute Brief Pharmacotherapy Visit (BPV), so that the alliance is nurtured and time is most efficiently utilized
  • Techniques, adapted from evidence-based psychotherapies, to enhance medication adherence in diverse youth populations
  • Approaches to adapt psychoeducation for culturally diverse populations, and considerwhy many youth & families may be skeptical of pharmacotherapeutic interventions
  • Strategies to cultivate a pharmacotherapeutic alliance when engaging with patients and families via telehealth, including in the school setting
  • Tips for pediatricians, advanced-practice clinicians, and other primary care providers who conduct pharmacotherapy

    The chapters feature key takeaways that distill the most salient points and that aid in knowledge retention.

    Rather than raise unrealistic expectations (two chapters acknowledge the reality of practicing when time and resources are scarce), the goal of this book is to help pharmacotherapists mitigate the stigma, apprehension, or resignation their patients may have and instead build and maintain a trusting relationship that will be key to successful therapeutic outcomes.

  • Contents

    • Uncovered
    • Prescriber, Prescribe Thyself (By Way of Introduction)
    • Chapter 1: Think Again About Prescribing: The Psychology of Psychopharmacology
    • Chapter 2: The Many Facets of Alliance: The Y-Model, Applied to Child, Adolescent, and Young Adult Psychopharmacotherapy
    • Chapter 3: Psychodynamics of Medication Use in Youth with Serious Mental Illness
    • Chapter 4: What's in It for Me?: Adapting Evidence-Based Motivational Interviewing and Therapy Techniques to Adolescent Psychiatry
    • Chapter 5: Providing Psychoeducation in Pharmacotherapy
    • Chapter 6: #KeepItReal: The Myth of the Med Check and the Realities of the Time-Limited Pharmacotherapy Visit
    • Chapter 7: Pharmacotherapy or Psychopharmacotherapy: When Therapist and Pharmacologist Are Different People, or the Same Person
    • Chapter 8: The Pharmacotherapeutic Role of the Pediatrician, Advanced Practice Clinician, and Other Primary Care Providers
    • Chapter 9: The Pharmacotherapeutic Alliance in School Mental Health
    • Chapter 10: When Time Is Tight and Stakes Are High: Pharmacotherapy, Alliances, and the Inpatient Unit
    • Chapter 11: Telepsychiatry Goes Viral: Psychotherapeutic Aspects of Prescribing Via Telemedicine Amid COVID-19
    • Chapter 12: Alliance Issues to Consider in Pharmacotherapy with Transition-Age Youth
    • Chapter 13: The Pharmacotherapeutic Alliance When Working with Diverse Youth and Families
    • Chapter 14: The Psychopharmacotherapeutic Alliance When Resources Are Limited
    • Chapter 15: Building a Therapeutic Alliance in Psychopharmacology During Clinical Trials: Ethical and Practical Considerations
    • Chapter 16: The Power of Placebo
    • Chapter 17: The Good Enough Pediatric Psychopharmacotherapist: Practical Pointers in Six Parables
    • Chapter 18: Teaching and Mentoring the Next Generation of Pediatric Psychopharmacotherapists
    • Gratitude

    Contributors

      John Azer, M.D.
      Barri Belnap, M.D.
      Jeff Q. Bostic, M.D., Ed.D.
      Arthur Caye, M.D., Ph.D.
      Janice Cho, M.D.
      Andrew Connor, D.O.
      Takesha Cooper, M.D., M.S.
      Jennifer Derenne, M.D.
      John J. DiLallo, M.D.
      Farrah Fang, M.D.
      Carl Feinstein, M.D.
      Erin Fletcher, M.D., M.P.H.
      Shih Yee-Marie Tan Gipson, M.D.
      Anne L. Glowinski, M.D., M.P.E.
      Srinivasa B. Gokarakonda, M.D., M.P.H.
      Simone Hasselmo, A.B.
      Amy Heneghan, M.D.
      Donald M. Hilty, M.D., M.B.A.
      David S. Hong, M.D.
      Peter S. Jensen, M.D.
      Shashank V. Joshi, M.D.
      Mandeep Kaur Kapur, M.D.
      David Kaye, M.D.
      Christian Kieling, M.D., Ph.D.
      Jung Won Kim, M.D.
      Brandon A. Kohrt, M.D., Ph.D.
      Mari Kurahashi, M.D., M.P.H.
      Nithya Mani, M.D.
      Andres Martin, M.D., M.P.H.
      Jeffrey A. Mills, Ph.D.
      David Mintz, M.D.
      Katherine M. Ort, M.D.
      Tara S. Paris, Ph.D.
      Kyle Pruett, M.D.
      Sean Pustilnik, M.D.
      Elizabeth Reichert, Ph.D.
      Magdalena Romanowicz, M.D.
      Max S. Rosen, M.D.
      Sarah Rosenbaum, M.D., M.P.H.
      Anthony L. Rostain, M.D., M.A.
      Erin Seery, M.D.
      Manpreet K. Singh, M.D., M.S.
      Jeffrey R. Strawn, M.D.
      Dorothy Stubbe, M.D.
      Andrea Tabuenca, Ph.D.
      Ian Tofler, M.B.B.S.
      Michelle Tom, M.D.
      John T. Walkup, M.D.
      Isheeta Zalpuri, M.D.

    About the Authors

    Shashank V. Joshi, M.D., is Professor of Psychiatry, Pediatrics, and Education at the Stanford University School of Medicine and Graduate School of Education, Director of School Mental Health at Lucile Packard Children's Hospital, and a Faculty Advisor at the Center for Comparative Studies in Race and Ethnicity (CCSRE), in Stanford, California.

    Andres Martin, M.D., M.P.H., is the Riva Ariella Ritvo Professor, Child Study Center, Yale School of Medicine, in New Haven, Connecticut. He is Medical Director of the Children's Psychiatric Inpatient Service at Yale New Haven Health, in New Haven, Connecticut.

    This collection is a treasure trove with the noble and timely aim of righting the erosion of what it means to be a child psychiatrist—and of what children and their families should mean to us. Clinicians will find in its pages an invitation to revisit the awesome responsibility that is to prescribe medicines by bridging the gap from the molecular to the relational.—Ajit N. Jetmalani, M.D., Director, Division of Child and Adolescent Psychiatry, Joseph Professor of Child Psychiatry Education, Oregon Health & Science University

    Related Products

    Become an APA Member
    Join Now